Project Grant R01AI181072
Award Date
11/8/24
Completion Date
10/31/29
Dollars Obligated
$500K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90095, USA
Similar Awards
This $162,512 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand how pathogen exposure and inflammation drive the expansion and function of long-lived effector CD8 T cells in the memory compartment. The key research objectives are to: 1) Determine what pro-inflammatory cytokines support the formation and persistence of long-lived effector CD8 T cells,...
This $995,244 federal Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 (Allergy and Infectious Diseases Research) aims to determine whether genetic mutations in the transcription factor ASCL1 contribute to the development of organ-specific autoimmunity. The project will investigate ASCL1's role in the function of medullary thymic epithelial cells, which are critical for establishing central tolerance and preventing autoimmunity. The...
This $172,909 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) funds research to uncover the role of the mitochondrial membrane phospholipid cardiolipin in promoting inflammatory cell death pathways. The overarching goal is to define the molecular mechanisms by which disruptions in mitochondrial homeostasis, including those driven by the LRRK2G2019S mutation, trigger the...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $239,348 to support research into CD1a-restricted T cells that recognize the lipid antigen phosphatidylglycerol (PG). The research aims to investigate the conditions under which mitochondrial PG becomes visible to these T cells, as well as compare the antigenicity of mammalian versus bacterial PG. Single-cell...
This federal Project Grant award, valued at $447,450 and provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to elucidate the molecular mechanisms underlying the limited response of CD38- lung-resident alveolar macrophages (AMs) to Mycobacterium tuberculosis (MTB) infection. The research aims to 1) decipher the host molecular mechanisms contributing to the blunted response of...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $649,053 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Washington University in St. Louis to investigate the role of Ly49 family receptors on CD8 T cells. The research aims to determine how Ly49 and the transcription factor Helios contribute to the development and function of CD8 regulatory T cells, which have been shown to suppress self-reactive CD4 T cells in autoimmune diseases. This...
This federal Project Grant award, valued at $2,483,910.00 and granted by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research into "Novel Mechanisms of Genetic Errors of Immunity." The key objectives of this multi-year, integrated research project are to: 1) investigate epigenetic mechanisms, including autosomal random monoallelic expression, that may contribute to variable...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $110,144 to Texas A&M University System Health Science Center (TAMU HSC) to conduct research aimed at understanding and reducing lung immunopathology associated with mitochondrial diseases. The research project seeks to investigate the role of the NRF2 transcription factor in promoting hyperinflammatory innate immune...
This $597,542 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), provided under CFDA Program 93.855 - Allergy and Infectious Diseases Research, supports research to investigate the metabolic and epigenetic regulation of skin regulatory T cells (Tregs) at Emory University. The primary objective is to dissect the specific metabolic program governing the homeostasis of skin Tregs within their microenvironment, and elucidate how this metabolic adaptation...
This Project Grant award, valued at $187,398, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports research to investigate the role of Programmed Death Ligand-1 (PD-L1) and CD80 in regulating dendritic cell migration and T cell priming. Specifically, the research aims to: 1) Define the extracellular interactions between PD-L1 and CD80 that govern dendritic cell migration, and...